A French study monitored patients with a mild form of the coronavirus. It was found that two-thirds of the 150 followed subjects continued to have some symptoms of the disease for one or two months
–
It is called “Post Covid” or “Long Covid” syndrome and it would be the trail of health problems that those infected by coronavirus they carry around for several weeks. Even if they contracted it mildly. Describing the clinical evolution of “non-critical” Covid-19 positives was the goal of a recent French study that followed 150 patients for two months. There Research, edited by the Tours University Hospital, was published on Monday 5 October in the scientific journal Clinical Microbiology and Infection (Cmi).
–
Problems for two thirds of the subjects studied
deepening
Covid-19 or flu: how to distinguish the symptoms
–
The two-month descriptive clinical follow-up involved 150 patients who contracted a non-critical form of coronavirus, followed from March 17 to June 3, 2020 after healing. On day 30, or day 60, of study i symptoms persistent were at least one of these: weight loss, dyspnoea, difficulty in breathing, severe, asthenia, chest pain, palpitations, loss of sense of smell and taste, headache, skin signs, arthralgia, myalgia, digestive disorders and finally the presence of temperature. This happened to two-thirds of the adults monitored, most frequently in those aged between 40 and 60. The conclusion that the researchers draw is that therefore, whatever the initial clinical status of Covid patients, prolonged medical follow-up is required for everyone once they seem to have overcome the virus because it can happen that problems recur even if they have contracted in a more livere form.
The numbers in detail
It was found that after thirty days 68% of patients presented at least one symptom, while 66% after sixty. Mainly it was a loss of taste and smell. Difficulty in breathing was felt by 55% of the patients, while half of them on day 30 of the study (and 40% on day 60) reported asthenia, i.e. loss of muscle strength and weakness. As mentioned after two months, persistent symptoms were significantly associated with positive people aged 40 to 60.
– .
